2Dematteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors; recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231(1):51-58.
3Boggino HE,Fernandez MP,Logrono R.Cytomorphology of gastrointestinal stromal tumor:diagnostic role of aspiration cytology,core biopsy,and immunochemistry[J].Diagn cytopathol,2000,23(3):156-160.
4Chhieng DC,Jhala D,Jhala N,et al.Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases[J].Cancer,2002,96(4):232-239.
5Pieria JP,Choudry U,Muzikansdy A,et al.The effect of surgery and grade on outcome of gastrointestinal stromal tumors[J].Arch Surg,2001,136(3):383-389.
7Hasegawa T,Matsuno Y,Shimoda T,et al.Gastrointestinal stromal tumors:consistent cd117 immunostaining for diagnosis and prognostic classification based on tumor size and MIB-1 grade[J].Hum Pathol,2002,33(6):669-676.
8Bilimoria MM,Holtz DJ,Mirza NQ,et al.Tumor volume as a prognostic factor for sarcomatosis[J].Cancer,2002,94(9):2441-2446.
9Heinrich MC,Griffith DJ,Druker BJ,et al.Inhibition of c-kit receptor tyrosine kinase activity by sti-571,a selective tyrosine kinase inhibitor[J].Blood,2000,96(3):925-932.
10Tuveson DA,Willis NA,Jacks T,et al.STI-571 inactivation of the gastrointestinal stromal tumor c-kit oncoprotein: biological and clinical implications[J].Oncogene,2001,20(36):5054-5058.
2Meittinen M, Lasola J. Gastrointestinal stromal tumors-definition,clinical, histological, immunohistochemical, and differential diagnosis. Virchows Arch, 2001, 438: 1-12.
3Bucldey JA, Fishman EK. CT evaluation of small bowel neoplasms: spectrum of disease. Radiographies, 1998, 18: 379-392.
4Palazzo L, Landi B, Cellier C, et al. Endosonographic features predictive of benign and malignant gastrointestinal stroma cell tumors. Gut, 2000, 46: 88-92.
5Chhieng DC, Jhala D, Jhala N, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases. Cancer,2002, 96: 232-239.
6Franqument DW, Frierson HF. Muscle differentiation and clinicopathologic features of gastrointestinal stromal cell tumors.Am J Surg Pathol, 1992, 16: 947.
7Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg, 1992, 215: 68-77.
8Crosby JA, Catton LN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small imtestine: a review of 50 cases from a prospective database. Ann Surg Oncol, 2001, 8: 50-59.
9DeMatteo R, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231: 51-58.
10Joensun H, Roberts PT, Sarlomo RM, et al. Effect of the tyrosine kinase inhibitor STI 571 in a patient with a metaslatic gastrointestinal stromal tumor. N Engl J Med, 2001, 344: 1052-1056.
